NPB Reports Q3 as CEO's Conviction Buy Sits Underwater

NPB has just reported Q3 results with the stock trading about 6% below the prices its own CEO paid in late August and early September, a gap that makes the earnings reaction the most consequential data point for Northpointe Bancshares in months.

The CEO's open-market buying remains the sharpest signal in the file. Chairman and Chief Executive Charles Williams spent roughly $2.75 million across three discretionary purchases, none executed under a 10b5-1 plan, at prices between $16.74 and $16.95. The stock closed Tuesday at $15.78, up 3% on the day but still well below those levels. The 90-day insider net across all insiders stands at roughly 145,000 shares bought for $2.4 million, with the director-level selling from David Hooker conducted entirely under a pre-arranged plan and too small in aggregate to read as a conviction signal. The CEO's position tells the more meaningful story: he bought aggressively as the stock retreated, and the market has not yet vindicated that view.

The borrow and positioning picture offers no meaningful pressure in either direction. Short interest is a modest 2.1% of free float, down about 5% over the past week after a brief spike around October 15. Borrow availability is extremely loose at over 2,800%, compared to a 52-week low of around 984%, meaning there is no shortage of shares to lend and no mechanical squeeze risk. Cost to borrow is negligible at 0.58%, and has fallen sharply over the week. This is a stock where short sellers are not a major force and where the borrow market tells no story worth emphasising.

The analyst community has been broadly constructive but has steadily trimmed targets after each earnings disappointment. Piper Sandler holds Overweight but cut its target from $21.50 to $20.00 earlier this month. Keefe, Bruyette & Woods holds Outperform at $21.00, down from $22.00 after the July print. The consensus mean target of $19.72 implies roughly 25% upside from current levels. That gap is wide for a regional bank, and the direction of travel on targets has been south. The stock trades at roughly 6x trailing earnings and 0.8x book, multiples that look undemanding if the mortgage warehouse business can maintain its growth path. The bear case centres on the company's heavy reliance on secondary-market loan sales and the sensitivity of that business to rate conditions. Bulls point to a mortgage purchase program portfolio tracking toward $3.3 to $3.5 billion at year-end and six consecutive quarters of asset and loan growth as reported by FDIC call report data.

On the ownership side, the register is concentrated and mostly passive. Castle Creek holds around 12.9%, Wellington 10.6% (trimmed last quarter), and Adage Capital has been a buyer, lifting its stake to 8.2%. None of the 13D/G filers on the register carry activist intent, all filed as Schedule 13G. Adage's most recent amendment showed its stake rising from 5.2% to 7.5%, a meaningful addition from a long-only manager that typically indicates conviction on valuation. Insider and institutional positioning are therefore pointing in the same direction, toward the stock looking cheap relative to book.

The previous session produced a single post-announcement earnings reaction worth noting: the July Q2 print triggered a 7.96% fall on the day and a 7.54% loss over the following five days, the only earnings reaction in the history data with price moves attached. That pattern establishes that Northpointe can move sharply on results, and with the Q3 print now released, how the stock holds its 3% intraday gain will signal whether the market's view is shifting or whether the July template reasserts itself.